Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Genetic Deletion of IL-19 (Interleukin-19) Exacerbates Atherogenesis in Il19-/-×Ldlr-/- Double Knockout Mice by Dysregulation of mRNA Stability Protein HuR (Human Antigen R).

Ray M, Gabunia K, Vrakas CN, Herman AB, Kako F, Kelemen SE, Grisanti LA, Autieri MV.

Arterioscler Thromb Vasc Biol. 2018 Jun;38(6):1297-1308. doi: 10.1161/ATVBAHA.118.310929. Epub 2018 Apr 19.

PMID:
29674474
2.

Impact of paroxetine on proximal β-adrenergic receptor signaling.

Guo S, Carter RL, Grisanti LA, Koch WJ, Tilley DG.

Cell Signal. 2017 Oct;38:127-133. doi: 10.1016/j.cellsig.2017.07.006. Epub 2017 Jul 12.

PMID:
28711716
3.

Interleukin-10 Inhibits Bone Marrow Fibroblast Progenitor Cell-Mediated Cardiac Fibrosis in Pressure-Overloaded Myocardium.

Verma SK, Garikipati VNS, Krishnamurthy P, Schumacher SM, Grisanti LA, Cimini M, Cheng Z, Khan M, Yue Y, Benedict C, Truongcao MM, Rabinowitz JE, Goukassian DA, Tilley D, Koch WJ, Kishore R.

Circulation. 2017 Sep 5;136(10):940-953. doi: 10.1161/CIRCULATIONAHA.117.027889. Epub 2017 Jun 30.

PMID:
28667100
4.

Cardiac GPCR-Mediated EGFR Transactivation: Impact and Therapeutic Implications.

Grisanti LA, Guo S, Tilley DG.

J Cardiovasc Pharmacol. 2017 Jul;70(1):3-9. doi: 10.1097/FJC.0000000000000462. Review.

5.

β2-Adrenergic receptor-dependent chemokine receptor 2 expression regulates leukocyte recruitment to the heart following acute injury.

Grisanti LA, Traynham CJ, Repas AA, Gao E, Koch WJ, Tilley DG.

Proc Natl Acad Sci U S A. 2016 Dec 27;113(52):15126-15131. doi: 10.1073/pnas.1611023114. Epub 2016 Dec 12.

6.

Vasopressin Type 1A Receptor Deletion Enhances Cardiac Contractility, β-Adrenergic Receptor Sensitivity and Acute Cardiac Injury-induced Dysfunction.

Wasilewski MA, Grisanti LA, Song J, Carter RL, Repas AA, Myers VD, Gao E, Koch WJ, Cheung JY, Feldman AM, Tilley D.

Clin Sci (Lond). 2016 Sep 2. pii: CS20160363. [Epub ahead of print]

7.

Skeletal Muscle-specific G Protein-coupled Receptor Kinase 2 Ablation Alters Isolated Skeletal Muscle Mechanics and Enhances Clenbuterol-stimulated Hypertrophy.

Woodall BP, Woodall MC, Luongo TS, Grisanti LA, Tilley DG, Elrod JW, Koch WJ.

J Biol Chem. 2016 Oct 14;291(42):21913-21924. Epub 2016 Aug 26.

8.

Leukocyte-Expressed β2-Adrenergic Receptors Are Essential for Survival After Acute Myocardial Injury.

Grisanti LA, Gumpert AM, Traynham CJ, Gorsky JE, Repas AA, Gao E, Carter RL, Yu D, Calvert JW, García AP, Ibáñez B, Rabinowitz JE, Koch WJ, Tilley DG.

Circulation. 2016 Jul 12;134(2):153-67. doi: 10.1161/CIRCULATIONAHA.116.022304. Epub 2016 Jun 30.

9.

Temporal and gefitinib-sensitive regulation of cardiac cytokine expression via chronic β-adrenergic receptor stimulation.

Grisanti LA, Repas AA, Talarico JA, Gold JI, Carter RL, Koch WJ, Tilley DG.

Am J Physiol Heart Circ Physiol. 2015 Feb 15;308(4):H316-30. doi: 10.1152/ajpheart.00635.2014. Epub 2014 Dec 5.

10.

GRK5-mediated exacerbation of pathological cardiac hypertrophy involves facilitation of nuclear NFAT activity.

Hullmann JE, Grisanti LA, Makarewich CA, Gao E, Gold JI, Chuprun JK, Tilley DG, Houser SR, Koch WJ.

Circ Res. 2014 Dec 5;115(12):976-85. doi: 10.1161/CIRCRESAHA.116.304475. Epub 2014 Oct 20.

11.

β-adrenergic receptor-mediated cardiac contractility is inhibited via vasopressin type 1A-receptor-dependent signaling.

Tilley DG, Zhu W, Myers VD, Barr LA, Gao E, Li X, Song J, Carter RL, Makarewich CA, Yu D, Troupes CD, Grisanti LA, Coleman RC, Koch WJ, Houser SR, Cheung JY, Feldman AM.

Circulation. 2014 Nov 11;130(20):1800-11. doi: 10.1161/CIRCULATIONAHA.114.010434. Epub 2014 Sep 9.

12.

β-adrenergic receptor-dependent alterations in murine cardiac transcript expression are differentially regulated by gefitinib in vivo.

Talarico JA, Carter RL, Grisanti LA, Yu JE, Repas AA, Tilley DG.

PLoS One. 2014 Jun 5;9(6):e99195. doi: 10.1371/journal.pone.0099195. eCollection 2014.

13.

Dynamic mass redistribution analysis of endogenous β-adrenergic receptor signaling in neonatal rat cardiac fibroblasts.

Carter RL, Grisanti LA, Yu JE, Repas AA, Woodall M, Ibetti J, Koch WJ, Jacobson MA, Tilley DG.

Pharmacol Res Perspect. 2014 Feb;2(1). doi: 10.1002/prp2.24.

14.

β-Adrenergic receptor-mediated transactivation of epidermal growth factor receptor decreases cardiomyocyte apoptosis through differential subcellular activation of ERK1/2 and Akt.

Grisanti LA, Talarico JA, Carter RL, Yu JE, Repas AA, Radcliffe SW, Tang HA, Makarewich CA, Houser SR, Tilley DG.

J Mol Cell Cardiol. 2014 Jul;72:39-51. doi: 10.1016/j.yjmcc.2014.02.009. Epub 2014 Feb 22.

15.

Differential activation of cultured neonatal cardiomyocytes by plasmalemmal versus intracellular G protein-coupled receptor 55.

Yu J, Deliu E, Zhang XQ, Hoffman NE, Carter RL, Grisanti LA, Brailoiu GC, Madesh M, Cheung JY, Force T, Abood ME, Koch WJ, Tilley DG, Brailoiu E.

J Biol Chem. 2013 Aug 2;288(31):22481-92. doi: 10.1074/jbc.M113.456178. Epub 2013 Jun 27.

16.

Phospholipase C not protein kinase C is required for the activation of TRPC5 channels by cholecystokinin.

Grisanti LA, Kurada L, Cilz NI, Porter JE, Lei S.

Eur J Pharmacol. 2012 Aug 15;689(1-3):17-24. doi: 10.1016/j.ejphar.2012.05.032. Epub 2012 Jun 7.

17.

Modulation of immune cell function by α(1)-adrenergic receptor activation.

Grisanti LA, Perez DM, Porter JE.

Curr Top Membr. 2011;67:113-38. doi: 10.1016/B978-0-12-384921-2.00006-9. Review. No abstract available.

18.

α1-adrenergic receptors positively regulate Toll-like receptor cytokine production from human monocytes and macrophages.

Grisanti LA, Woster AP, Dahlman J, Sauter ER, Combs CK, Porter JE.

J Pharmacol Exp Ther. 2011 Aug;338(2):648-57. doi: 10.1124/jpet.110.178012. Epub 2011 May 13.

19.

Pro-inflammatory responses in human monocytes are beta1-adrenergic receptor subtype dependent.

Grisanti LA, Evanson J, Marchus E, Jorissen H, Woster AP, DeKrey W, Sauter ER, Combs CK, Porter JE.

Mol Immunol. 2010 Mar;47(6):1244-54. doi: 10.1016/j.molimm.2009.12.013. Epub 2010 Jan 29.

20.

The 27-kDa heat shock protein confers cytoprotective effects through a beta 2-adrenergic receptor agonist-initiated complex with beta-arrestin.

Rojanathammanee L, Harmon EB, Grisanti LA, Govitrapong P, Ebadi M, Grove BD, Miyagi M, Porter JE.

Mol Pharmacol. 2009 Apr;75(4):855-65. doi: 10.1124/mol.108.053397. Epub 2009 Jan 27.

Supplemental Content

Loading ...
Support Center